SU6668 modulates prostate cancer progression by downregulating MTDH/AKT signaling pathway

Prostate cancer is the second leading cause of cancer deaths among men in Western counties and has increased in incidence also in China in recent years. Although diagnosis modalities for primary prostate cancer have markedly improved, there are still no effective therapies for metastatic prostate ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Benjiang, Yao, Yi, Liu, Changming, Zhang, Jiabing, Chen, Huihong, Li, Huizhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403372/
https://www.ncbi.nlm.nih.gov/pubmed/28339027
http://dx.doi.org/10.3892/ijo.2017.3926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403372/
https://www.ncbi.nlm.nih.gov/pubmed/28339027
http://dx.doi.org/10.3892/ijo.2017.3926

Ejemplares similares